The Cochrane Library: Cochrane Database of Systematic Reviews

DOI: 10.1002/14651858

Reviews/Protocols listed by Cochrane Review Group


  1. Cochrane Acute Respiratory Infections Group
  2. Cochrane Airways Group
  3. Cochrane Anaesthesia Group
  4. Cochrane Back Group
  5. Cochrane Bone, Joint and Muscle Trauma Group
  6. Cochrane Breast Cancer Group
  7. Cochrane Childhood Cancer Group
  8. Cochrane Colorectal Cancer Group
  9. Cochrane Consumers and Communication Group
  10. Cochrane Cystic Fibrosis and Genetic Disorders Group
  11. Cochrane Dementia and Cognitive Improvement Group
  12. Cochrane Depression, Anxiety and Neurosis Group
  13. Cochrane Developmental, Psychosocial and Learning Problems Group
  14. Cochrane Drugs and Alcohol Group
  15. Cochrane Ear, Nose and Throat Disorders Group
  16. Cochrane Effective Practice and Organisation of Care Group
  17. Cochrane Epilepsy Group
  18. Cochrane Eyes and Vision Group
  19. Cochrane Fertility Regulation Group
  20. Cochrane Gynaecological Cancer Group
  21. Cochrane Haematological Malignancies Group
  22. Cochrane Heart Group
    1. About this group
    2. Reviews
      1. Active chest compression-decompression for cardiopulmonary resuscitationReview
      2. Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarctionReview
      3. Adenosine versus intravenous calcium channel antagonists for the treatment of supraventricular tachycardia in adultsReview
      4. Aminophylline for bradyasystolic cardiac arrest in adultsReview
      5. Angiotensin receptor blockers for heart failureReview
      6. Anti-inflammatory treatment for carditis in acute rheumatic feverReview
      7. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillationReview
      8. Antibiotics for brain abscesses in people with cyanotic congenital heart diseaseReview
      9. Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutterReviewWithdrawn
      10. Anticoagulation versus placebo for heart failure in sinus rhythmReview
      11. Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythmReview
      12. Antiplatelet and anticoagulation for patients with prosthetic heart valvesReview
      13. Artichoke leaf extract for treating hypercholesterolaemiaReview
      14. Bed rest for acute uncomplicated myocardial infarctionReview
      15. Beta-blockers for congestive heart failure in childrenReview
      16. Cardiac rehabilitation for people with heart disease: an overview of Cochrane systematic reviewsReviewOverview
      17. Catheter ablation for paroxysmal and persistent atrial fibrillationReview
      18. Chinese herbal medicine suxiao jiuxin wan for angina pectorisReview
      19. Chuanxiong preparations for preventing strokeReview
      20. Clinical service organisation for heart failureReview
      21. Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular diseaseReview
      22. Co-enzyme Q10 supplementation for the primary prevention of cardiovascular diseaseReview
      23. Coenzyme Q10 for heart failureReview
      24. Colchicine for pericarditisReview
      25. Continuous infusion versus bolus injection of loop diuretics in congestive heart failureReview
      26. Corticosteroids for viral myocarditisReview
      27. Danshen (Chinese medicinal herb) preparations for acute myocardial infarctionReview
      28. Dietary advice for reducing cardiovascular riskReview
      29. Digitalis for treatment of heart failure in patients in sinus rhythmReview
      30. Diuretics for heart failureReview
      31. Drug-eluting stents versus bare metal stents for angina or acute coronary syndromesReview
      32. Drugs and pacemakers for vasovagal, carotid sinus and situational syncopeReview
      33. Dual chamber versus single chamber ventricular pacemakers for sick sinus syndrome and atrioventricular blockReview
      34. Early invasive versus conservative strategies for unstable angina and non-ST elevation myocardial infarction in the stent eraReview
      35. Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillationReview
      36. Effectiveness of systematic screening for the detection of atrial fibrillationReview
      37. Effectiveness of the Valsalva Manoeuvre for reversion of supraventricular tachycardiaReview
      38. Electrical cardioversion for atrial fibrillation and flutterReview
      39. Enhanced external counterpulsation for chronic angina pectorisReview
      40. Erythropoiesis-stimulating agents for anaemia in chronic heart failure patientsReview
      41. Exercise-based cardiac rehabilitation for coronary heart diseaseReview
      42. Exercise-based rehabilitation for heart failureReview
      43. Exercise for people with high cardiovascular riskReview
      44. Face-to-face interventions for promoting physical activityReview
      45. Face-to-face versus remote and web 2.0 interventions for promoting physical activityReview
      46. Factor Xa inhibitors for acute coronary syndromesReview
      47. Fixed-dose combination therapy for the prevention of cardiovascular diseaseReview
      48. Ganoderma lucidum mushroom for the treatment of cardiovascular risk factorsReview
      49. Granulocyte colony stimulating factor therapy for acute myocardial infarctionReview
      50. Green and black tea for the primary prevention of cardiovascular diseaseReview
      51. Hawthorn extract for treating chronic heart failureReview
      52. Heparin versus placebo for non-ST elevation acute coronary syndromesReview
      53. Herbal medicines for viral myocarditisReview
      54. Home-based versus centre-based cardiac rehabilitationReview
      55. Homocysteine-lowering interventions for preventing cardiovascular eventsReview
      56. Hormone therapy for preventing cardiovascular disease in post-menopausal womenReviewNew Search
      57. Hyperbaric oxygen therapy for acute coronary syndromeReview
      58. Hypothermia to reduce neurological damage following coronary artery bypass surgeryReview
      59. Immunosuppressive T-cell antibody induction for heart transplant recipientsReview
      60. Incentive spirometry for preventing pulmonary complications after coronary artery bypass graftReview
      61. Increased consumption of fruit and vegetables for the primary prevention of cardiovascular diseasesReview
      62. Influenza vaccines for preventing coronary heart diseaseReview
      63. Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndromeReview
      64. Interventions for increasing fruit and vegetable consumption in children aged 5 years and underReview
      65. Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgeryReview
      66. Interventions for promoting physical activityReview
      67. Interventions for treating obesity in childrenReview
      68. Interventions to improve adherence to lipid lowering medicationReview
      69. Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shockReviewNew Search
      70. Intravenous immunoglobulin for presumed viral myocarditis in children and adultsReview
      71. Intravenous magnesium for acute myocardial infarctionReview
      72. Leukodepletion for patients undergoing heart valve surgeryReview
      73. Lipid-lowering efficacy of atorvastatinReviewNew Search
      74. Lipid-lowering efficacy of rosuvastatinReview
      75. Low glycaemic index diets for coronary heart diseaseReview
      76. Low molecular weight heparins versus unfractionated heparin for acute coronary syndromesReview
      77. Mechanical versus manual chest compressions for cardiac arrestReview
      78. Mediastinal chest drain clearance for cardiac surgeryReview
      79. 'Mediterranean' dietary pattern for the primary prevention of cardiovascular diseaseReview
      80. Multiple risk factor interventions for primary prevention of coronary heart diseaseReview
      81. Music for stress and anxiety reduction in coronary heart disease patientsReview
      82. Nitrates for acute heart failure syndromesReview
      83. Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedemaReview
      84. Off-pump versus on-pump coronary artery bypass grafting for ischaemic heart diseaseReview
      85. Omega 3 fatty acids for prevention and treatment of cardiovascular diseaseReview
      86. Optimal loading dose of warfarin for the initiation of oral anticoagulationReview
      87. Oxygen therapy for acute myocardial infarctionReview
      88. Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathyReview
      89. Patient education in the management of coronary heart diseaseReview
      90. Penicillin for secondary prevention of rheumatic feverReview
      91. Percutaneous transluminal coronary angioplasty with stents versus coronary artery bypass grafting for people with stable angina or acute coronary syndromesReview
      92. Percutaneous transluminal rotational atherectomy for coronary artery diseaseReview
      93. Pharmacological cardioversion for atrial fibrillation and flutterReview
      94. Pharmacological interventions for treating heart failure in patients with Chagas cardiomyopathyReview
      95. Phosphodiesterase III inhibitors for heart failureReview
      96. Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromesReview
      97. Pre-hospital versus in-hospital thrombolysis for ST-elevation myocardial infarctionReview
      98. Preoperative intra aortic balloon pumps in patients undergoing coronary artery bypass graftingReview
      99. Preoperative physical therapy for elective cardiac surgery patientsReview
      100. Preoperative statin therapy for patients undergoing cardiac surgeryReview
      101. Primary angioplasty versus intravenous thrombolysis for acute myocardial infarctionReviewWithdrawn
      102. Primary stenting versus primary balloon angioplasty for treating acute myocardial infarctionReview
      103. Promoting patient uptake and adherence in cardiac rehabilitationReview
      104. Prophylactic corticosteroids for cardiopulmonary bypass in adultsReview
      105. Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart diseaseReviewNew
      106. Prophylactic steroids for pediatric open heart surgeryReview
      107. Psychological and pharmacological interventions for depression in patients with coronary artery diseaseReview
      108. Psychological interventions for coronary heart diseaseReview
      109. Psychological interventions for depression in adolescent and adult congenital heart diseaseReview
      110. Psychological interventions for depression in heart failureReview
      111. Psychological interventions for symptomatic management of non-specific chest pain in patients with normal coronary anatomyReview
      112. Psychosocial interventions for smoking cessation in patients with coronary heart diseaseReview
      113. Puerarin injection for unstable angina pectorisReview
      114. Red cell transfusion management for patients undergoing cardiac surgery for congenital heart diseaseReview
      115. Reduced dietary salt for the prevention of cardiovascular diseaseReview
      116. Reduced or modified dietary fat for preventing cardiovascular diseaseReview
      117. Remote and web 2.0 interventions for promoting physical activityReview
      118. Selenium supplementation for the primary prevention of cardiovascular diseaseReview
      119. Self-monitoring and self-management of oral anticoagulationReview
      120. Service organisation for the secondary prevention of ischaemic heart disease in primary careReview
      121. Shengmai (a traditional Chinese herbal medicine) for heart failureReview
      122. Smoking cessation for the secondary prevention of coronary heart diseaseReview
      123. Statins for acute coronary syndromeReview
      124. Statins for the primary prevention of cardiovascular diseaseReview
      125. Stem cell therapy for chronic ischaemic heart disease and congestive heart failureReview
      126. Stem cell treatment for acute myocardial infarctionReview
      127. Structured telephone support or telemonitoring programmes for patients with chronic heart failureReview
      128. Tai chi for primary prevention of cardiovascular diseaseReview
      129. Ticlopidine versus oral anticoagulation for coronary stentingReview
      130. Tongxinluo (Tong xin luo or Tong-xin-luo) capsule for unstable angina pectorisReview
      131. Traditional Chinese herbal products for stable anginaReview
      132. Transcendental meditation for the primary prevention of cardiovascular diseaseReview
      133. Transmyocardial laser revascularization versus medical therapy for refractory anginaReview
      134. Trimetazidine for stable anginaReview
      135. Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infectionReview
      136. Trypanocidal drugs for late stage, symptomatic Chagas disease (Trypanosoma cruzi infection)Review
      137. Vitamin K for improved anticoagulation control in patients receiving warfarinReview
      138. Wholegrain cereals for coronary heart diseaseReview
      139. Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart diseaseReview
      140. Yoga for secondary prevention of coronary heart diseaseReview
      141. Yoga for the primary prevention of cardiovascular diseaseReview
    3. Protocols
      1. Acupuncture for angina pectorisProtocol
      2. Adrenaline and vasopressin for cardiac arrestProtocol
      3. Amiodarone versus other pharmacological interventions for prevention of sudden cardiac deathProtocol
      4. Angiotensin-converting enzyme inhibitors for congestive heart failure in childrenProtocol
      5. Antibiotic therapy for treatment of infective endocarditisProtocol
      6. Antibiotics for secondary prevention of coronary heart diseaseProtocol
      7. Aspirin for primary prevention of coronary heart diseaseProtocol
      8. B-type natriuretic peptide-guided treatment for heart failureProtocol
      9. Beta-blockers for heart failureProtocol
      10. Beta-blockers for myocardial infarctionProtocol
      11. Beta-blockers for preventing aortic dissection in Marfan's syndromeProtocol
      12. Beta-blockers for unstable anginaProtocol
      13. Bilateral versus single internal mammary artery bypass grafts for coronary arterial atherosclerosisProtocol
      14. Biphasic versus monophasic waveforms for transthoracic defibrillation in out-of-hospital cardiac arrestProtocol
      15. Bypass for primary percutaneous intervention or thrombolysis at the nearest hospital for patients suffering ST-elevation myocardial infarctionProtocol
      16. Cardiac resynchronization therapy for dilated cardiomyopathyProtocol
      17. Cardiovascular safety of phosphodiesterase inhibitors for treating erectile dysfunction in elderly menProtocol
      18. Chest pain observation units for patients with symptoms suggestive of acute cardiac ischaemiaProtocol
      19. Chronotherapy versus conventional statins therapy for the treatment of hyperlipidaemiaProtocol
      20. Colchicine for prevention of cardiovascular eventsProtocol
      21. Computer-assisted versus oral-and-written history taking for the management of cardiovascular diseaseProtocol
      22. Computer-assisted versus oral-and-written history taking for the prevention of cardiovascular diseaseProtocol
      23. Cryoablation versus radiofrequency catheter ablation for AV nodal re-entrant tachycardiaProtocol
      24. Dietary fibre for the primary prevention of cardiovascular diseaseProtocol
      25. Direct thrombin inhibitors and factor Xa inhibitors for atrial fibrillationProtocol
      26. Educational interventions for adults to prevent readmission and complications following cardiovascular surgeryProtocol
      27. Endothelial progenitor cell capture stents versus drug-eluting stents for angina or acute coronary syndromeProtocol
      28. Exercise-based cardiac rehabilitation for adults after heart valve surgeryProtocol
      29. Exercise-based cardiac rehabilitation for adults with atrial fibrillationProtocol
      30. Fibrates for primary prevention of cardiovascular disease eventsProtocol
      31. Fibrates for secondary prevention of cardiovascular disease and strokeProtocol
      32. Fresh frozen plasma for cardiovascular surgeryProtocol
      33. Glucocorticoids for decompensated heart failureProtocol
      34. Glycaemic control for patients with acute coronary syndromeProtocol
      35. Health, not weight loss, focused programmes versus conventional weight loss programmes for cardiovascular risk factorsProtocol
      36. Implantable defibrillators versus medical therapy for cardiac channelopathiesProtocol
      37. Implantable loop recorder versus conventional diagnostic workup for unexplained recurrent syncopeProtocolNew
      38. Internet based interventions for the secondary prevention of coronary heart diseaseProtocol
      39. Interventions for the prevention of postoperative atrial fibrillation in adult patients undergoing noncardiac thoracic surgeryProtocol
      40. Interventions to improve evidence-based prescribing in heart failureProtocol
      41. Interventions to increase physical activity for people with congenital heart diseaseProtocol
      42. Ivabradine as adjuvant treatment for chronic heart failureProtocol
      43. Mammalian target of rapamycin inhibitors for heart transplant patientsProtocol
      44. Multiple risk factor interventions for primary prevention of cardiovascular disease in low- and middle-income countriesProtocol
      45. Niacin for primary and secondary prevention of cardiovascular eventsProtocol
      46. Nurse-led titration of angiotensin converting enzyme inhibitors, beta-adrenergic blocking agents and angiotensin receptor blockers for patients with left ventricular systolic dysfunctionProtocol
      47. Nut consumption for the primary prevention of cardiovascular diseaseProtocolNew
      48. Omega 6 fatty acids for the primary prevention of cardiovascular diseaseProtocol
      49. Opioids for treating dyspnoea in patients with chronic heart failureProtocol
      50. Primary immunosuppression following heart transplantationProtocol
      51. Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart diseaseProtocol
      52. Prophylactic lidocaine for myocardial infarctionProtocol
      53. Qigong for the primary prevention of cardiovascular diseaseProtocol
      54. Reduced salt intake for heart failureProtocol
      55. Risk scoring for the primary prevention of cardiovascular diseaseProtocol
      56. Sexual counselling for sexual problems in patients with cardiovascular diseaseProtocol
      57. Statins for aortic valve stenosisProtocol
      58. Supplemental plant sterols and stanols for serum cholesterol and cardiovascular diseaseProtocol
      59. Systematic versus opportunistic risk assessment for the primary prevention of cardiovascular diseaseProtocol
      60. Tong-xin-luo capsule for patients with coronary heart disease after percutaneous coronary interventionProtocol
      61. Transcatheter valve implantation versus aortic valve replacement for aortic stenosis in high-risk patientsProtocol
      62. Transcatheter versus optimal medical treatment and surgical aortic valve replacement for aortic valve stenosisProtocol
      63. The use of antiarrhythmics prior to cardioversion or catheter ablation for atrial fibrillationProtocol
      64. Vasopressors and predominantly vasoconstrictive drugs for acute myocardial infarction complicated by cardiogenic shockProtocolNew
      65. Vitamin C for treating atrial fibrillationProtocol
      66. Vitamin C supplementation for the primary prevention of cardiovascular diseaseProtocol
      67. Vitamin K for the primary prevention of cardiovascular diseaseProtocol
  23. Cochrane Hepato-Biliary Group
  24. Cochrane HIV/AIDS Group
  25. Cochrane Hypertension Group
  26. Cochrane Incontinence Group
  27. Cochrane Infectious Diseases Group
  28. Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Group
  29. Cochrane Injuries Group
  30. Cochrane Lung Cancer Group
  31. Cochrane Menstrual Disorders and Subfertility Group
  32. Cochrane Metabolic and Endocrine Disorders Group
  33. Cochrane Methodology Review Group
  34. Cochrane Movement Disorders Group
  35. Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Group
  36. Cochrane Musculoskeletal Group
  37. Cochrane Neonatal Group
  38. Cochrane Neuromuscular Disease Group
  39. Cochrane Occupational Safety and Health Group
  40. Cochrane Oral Health Group
  41. Cochrane Pain, Palliative and Supportive Care Group
  42. Cochrane Peripheral Vascular Diseases Group
  43. Cochrane Pregnancy and Childbirth Group
  44. Cochrane Prostatic Diseases and Urologic Cancers Group
  45. Cochrane Public Health Group
  46. Cochrane Renal Group
  47. Cochrane Schizophrenia Group
  48. Cochrane Sexually Transmitted Infections Group
  49. Cochrane Skin Group
  50. Cochrane Stroke Group
  51. Cochrane Tobacco Addiction Group
  52. Cochrane Upper Gastrointestinal and Pancreatic Diseases Group
  53. Cochrane Wounds Group

SEARCH